Printed from https://ideas.repec.org/s/sae/medema5.html
Content
August 2016, Volume 36, Issue 6
- 703-713 Factors Affecting Physicians’ Intentions to Communicate Personalized Prognostic Information to Cancer Patients at the End of Life
by Paul K. J. Han & Nathan F. Dieckmann & Christina Holt & Caitlin Gutheil & Ellen Peters - 714-725 What Is a “Good†Treatment Decision? Decisional Control, Knowledge, Treatment Decision Making, and Quality of Life in Men with Clinically Localized Prostate Cancer
by Heather Orom & Caitlin Biddle & Willie Underwood III & Christian J. Nelson & D. Lynn Homish - 726-740 A Patient-Centered Approach to Informed Consent
by Tamar Krishnamurti & Nichole Argo - 741-759 Self-Management Skills in Chronic Disease Management
by Laura M. Mackey & Catherine Doody & Erik L. Werner & Brona Fullen - 760-776 Effects of Design Features of Explicit Values Clarification Methods
by Holly O. Witteman & Teresa Gavaruzzi & Laura D. Scherer & Arwen H. Pieterse & Andrea Fuhrel-Forbis & Selma Chipenda Dansokho & Nicole Exe & Valerie C. Kahn & Deb Feldman-Stewart & Nananda F. Col & Alexis F. Turgeon & Angela Fagerlin - 777-790 Extent and Predictors of Decision Regret about Health Care Decisions
by Maria Margarita Becerra Pérez & Matthew Menear & Jamie C. Brehaut & France Légaré
July 2016, Volume 36, Issue 5
- 78-415 37th Annual Meeting of the Society for Medical Decision Making
by N/A - 416-445 Author Index for Abstracts
by N/A - 567-580 A Framework for Prioritizing Research Investments in Precision Medicine
by Anirban Basu & Josh J. Carlson & David L. Veenstra - 581-593 Using Active Learning for Speeding up Calibration in Simulation Models
by Mucahit Cevik & Mehmet Ali Ergun & Natasha K. Stout & Amy Trentham-Dietz & Mark Craven & Oguzhan Alagoz - 594-603 Comparative Effectiveness of Biomarkers to Target Cancer Treatment
by Jeanette K. Birnbaum & Foluso O. Ademuyiwa & Josh J. Carlson & Leslie Mallinger & Mark W. Mason & Ruth Etzioni - 604-614 Validation of Models Used to Inform Colorectal Cancer Screening Guidelines
by Carolyn M. Rutter & Amy B. Knudsen & Tracey L. Marsh & V. Paul Doria-Rose & Eric Johnson & Chester Pabiniak & Karen M. Kuntz & Marjolein van Ballegooijen & Ann G. Zauber & Iris Lansdorp-Vogelaar - 615-628 Applying the Longitudinal Model from Item Response Theory to Assess Health-Related Quality of Life in the PRODIGE 4/ACCORD 11 Randomized Trial
by Antoine Barbieri & Amélie Anota & Thierry Conroy & Sophie Gourgou-Bourgade & Beata Juzyna & Franck Bonnetain & Christian Lavergne & Caroline Bascoul-Mollevi - 629-640 Structural Uncertainty of Markov Models for Advanced Breast Cancer
by Quang A. Le - 641-651 Development and Evaluation of an Approach to Using Value of Information Analyses for Real-Time Prioritization Decisions Within SWOG, a Large Cancer Clinical Trials Cooperative Group
by Caroline S. Bennette & David L. Veenstra & Anirban Basu & Laurence H. Baker & Scott D. Ramsey & Josh J. Carlson - 652-665 Calibrating Parameters for Microsimulation Disease Models
by Alex van der Steen & Joost van Rosmalen & Sonja Kroep & Frank van Hees & Ewout W. Steyerberg & Harry J. de Koning & Marjolein van Ballegooijen & Iris Lansdorp-Vogelaar - 666-679 The Role of Decision Models in Health Care Policy
by Ava John-Baptiste & Marilyn M. Schapira & Catherine Cravens & James D. Chambers & Peter J. Neumann & Joanna Siegel & William Lawrence
May 2016, Volume 36, Issue 4
- 1-77 2nd Asia-Pacific Conference of the Society for Medical Decision Making
by N/A - 427-452 The Impact of Patient Participation in Health Decisions Within Medical Encounters
by Marla L. Clayman & Carma L. Bylund & Betty Chewning & Gregory Makoul - 453-471 Design Features of Explicit Values Clarification Methods
by Holly O. Witteman & Laura D. Scherer & Teresa Gavaruzzi & Arwen H. Pieterse & Andrea Fuhrel-Forbis & Selma Chipenda Dansokho & Nicole Exe & Valerie C. Kahn & Deb Feldman-Stewart & Nananda F. Col & Alexis F. Turgeon & Angela Fagerlin - 472-478 Goals and Social Comparisons Promote Walking Behavior
by Gretchen B. Chapman & Helen Colby & Kimberly Convery & Elliot J. Coups - 479-489 Unknown Risks
by Laura L. Blaisdell & Caitlin Gutheil & Norbert A. M. Hootsmans & Paul K. J. Han - 490-502 Does Introducing Imprecision around Probabilities for Benefit and Harm Influence the Way People Value Treatments?
by Nick Bansback & Mark Harrison & Carlo Marra - 503-517 In Sickness but Not in Wealth
by Matteo M. Galizzi & Marisa Miraldo & Charitini Stavropoulou - 518-525 Shared Medical Decision Making in Lung Cancer Screening
by Liana Fraenkel & Ellen Peters & Shea Tyra & David Oelberg - 526-535 Risk Stratification and Shared Decision Making for Colorectal Cancer Screening
by Paul C. Schroy III & Emir Duhovic & Clara A. Chen & Timothy C. Heeren & William Lopez & Danielle L. Apodaca & John B. Wong - 536-540 The Wisdom of Crowds of Doctors
by Michael W. Kattan & Colin O’Rourke & Changhong Yu & Kevin Chagin - 541-549 Can Medical Diagnosis Benefit from “Unconscious Thought†?
by Amanda Woolley & Olga Kostopoulou & Brendan C. Delaney - 550-556 Effect of Health Literacy on Decision-Making Preferences among Medically Underserved Patients
by Joann Seo & Melody S. Goodman & Mary Politi & Melvin Blanchard & Kimberly A. Kaphingst - 557-561 Uptake and Documentation of the Use of an Encounter Decision Aid in Usual Practice
by Jonathan Inselman & Megan Branda & Ana Castaneda-Guarderas & Michael R. Gionfriddo & Claudia L. Zeballos-Palacios & Megan M. Morris & Nilay D. Shah & Victor M. Montori & Annie LeBlanc
April 2016, Volume 36, Issue 3
- 279-281 Medical Decision Making Reviewers, 2015
by N/A - 282-283 Expected Value of Sample Information with Imperfect Implementation
by Simon Eckermann & Andrew R. Willan - 284-284 Adjusting Expected Value of Sample Information Using Realistic Expectations around Implementation
by Lazaros Andronis & Pelham M. Barton - 285-295 Interpretation of the Expected Value of Perfect Information and Research Recommendations
by Joanna Thorn & Joanna Coast & Lazaros Andronis - 296-307 Adjusting Estimates of the Expected Value of Information for Implementation
by Lazaros Andronis & Pelham M. Barton - 308-320 An Efficient Estimator for the Expected Value of Sample Information
by Nicolas A. Menzies - 321-334 A Practical Application of Value of Information and Prospective Payback of Research to Prioritize Evaluative Research
by Lazaros Andronis & Lucinda J. Billingham & Stirling Bryan & Nicholas D. James & Pelham M. Barton - 335-348 Efficient Research Design
by Edward C. F. Wilson & Miranda Mugford & Garry Barton & Lee Shepstone - 349-365 Using Dual Beta Distributions to Create “Proper†ROC Curves Based on Rating Category Data
by Douglas Mossman & Hongying Peng - 366-374 A Decision Analysis of Percutaneous Left Atrial Appendage Occlusion Relative to Novel and Traditional Oral Anticoagulation for Stroke Prevention in Patients with New-Onset Atrial Fibrillation
by Andrew Micieli & Harindra C. Wijeysundera & Feng Qiu & Clare L. Atzema & Sheldon M. Singh - 375-390 Lessons Learned from a Cross-Model Validation between a Discrete Event Simulation Model and a Cohort State-Transition Model for Personalized Breast Cancer Treatment
by Beate Jahn & Ursula Rochau & Christina Kurzthaler & Mike Paulden & Martina Kluibenschädl & Marjan Arvandi & Felicitas Kühne & Alexander Goehler & Murray D. Krahn & Uwe Siebert - 391-409 HIV Treatment and Prevention
by Jessie L. Juusola & Margaret L. Brandeau - 410-421 Methods for Building and Validating Equations for Physiology-Based Mathematical Models
by David M. Eddy & Leonard Schlessinger
February 2016, Volume 36, Issue 2
- 147-159 Measuring the Sensitivity and Construct Validity of 6 Utility Instruments in 7 Disease Areas
by Jeff Richardson & Angelo Iezzi & Munir A. Khan & Gang Chen & Aimee Maxwell - 160-175 Mapping between 6 Multiattribute Utility Instruments
by Gang Chen & Munir A. Khan & Angelo Iezzi & Julie Ratcliffe & Jeff Richardson - 176-186 A Framework for Including Family Health Spillovers in Economic Evaluation
by Hareth Al-Janabi & Job van Exel & Werner Brouwer & Joanna Coast - 187-198 Altruistic Preferences in Time Tradeoff
by Marieke Krol & Arthur E. Attema & Job van Exel & Werner Brouwer - 199-209 Valuation of Child Behavioral Problems from the Perspective of US Adults
by Benjamin M. Craig & Derek S. Brown & Bryce B. Reeve - 210-222 Eliciting Societal Preferences for Weighting QALYs for Burden of Illness and End of Life
by Donna Rowen & John Brazier & Clara Mukuria & Anju Keetharuth & Arne Risa Hole & Aki Tsuchiya & Sophie Whyte & Phil Shackley - 223-233 Quantifying Parameter Uncertainty in EQ-5D-3L Value Sets and Its Impact on Studies That Use the EQ-5D-3L to Measure Health Utility
by Eleanor M. Pullenayegum & Kelvin K. W. Chan & Feng Xie - 234-241 Valuing Health-Related Quality of Life in Type 2 Diabetes Patients in China
by Chen-Wei Pan & Hong-Peng Sun & Hui-Jun Zhou & Qinghua Ma & Yong Xu & Nan Luo & Pei Wang - 242-252 Logical Inconsistencies in 3 Preference Elicitation Methods for EQ-5D Health States
by Mônica Viegas Andrade & Kenya Noronha & Paul Kind & Carla de Barros Reis & Lucas Resende de Carvalho - 253-263 Brazilian Valuation of EQ-5D-3L Health States
by Marisa Santos & Monica A. C. T. Cintra & Andrea L. Monteiro & Braulio Santos & Fernando Gusmão-filho & Mônica Viegas Andrade & Kenya Noronha & Luciane N. Cruz & Suzi Camey & Bernardo Tura & Paul Kind - 264-274 Health Condition Impacts in a Nationally Representative Cross-Sectional Survey Vary Substantially by Preference-Based Health Index
by Janel Hanmer & Dasha Cherepanov & Mari Palta & Robert M. Kaplan & David Feeny & Dennis G. Fryback
January 2016, Volume 36, Issue 1
- 3-4 Introducing MDM Policy & Practice
by Alan J. Schwartz - 5-7 Increasing the Expected Value to Society of Clinical Research Studies?
by Helena Chmura Kraemer - 8-19 Distributional Cost-Effectiveness Analysis
by Miqdad Asaria & Susan Griffin & Richard Cookson - 20-30 Are There Scenarios When the Use of Non–Placebo-Control Groups in Experimental Trial Designs Increase Expected Value to Society?
by Jennifer Uyei & R. Scott Braithwaite - 31-47 Mind the Gap! A Multilevel Analysis of Factors Related to Variation in Published Cost-Effectiveness Estimates within and between Countries
by Christian E. H. Boehler & Joanne Lord - 48-58 A Simulation Modeling Framework to Optimize Programs Using Financial Incentives to Motivate Health Behavior Change
by Sanjay Basu & Michaela Kiernan - 59-71 Continuous-Time Semi-Markov Models in Health Economic Decision Making
by Qi Cao & Erik Buskens & Talitha Feenstra & Tiny Jaarsma & Hans Hillege & Douwe Postmus - 72-85 Expansion of the National Salt Reduction Initiative
by Sung Eun Choi & Margaret L. Brandeau & Sanjay Basu - 86-100 Multistate Statistical Modeling
by Mathilda L. Bongers & Dirk de Ruysscher & Cary Oberije & Philippe Lambin & Carin A. Uyl–de Groot & V. M. H. Coupé - 101-114 Empirical Treatment Effectiveness Models for Binary Outcomes
by Jarrod E. Dalton & Neal V. Dawson & Daniel I. Sessler & Jesse D. Schold & Thomas E. Love & Michael W. Kattan - 115-131 Theoretical Foundations and Practical Applications of Within-Cycle Correction Methods
by Elamin H. Elbasha & Jagpreet Chhatwal - 132-136 An Efficient, Noniterative Method of Identifying the Cost-Effectiveness Frontier
by Sze-chuan Suen & Jeremy D. Goldhaber-Fiebert - 137-144 The Impact of Oversampling with SMOTE on the Performance of 3 Classifiers in Prediction of Type 2 Diabetes
by Azra Ramezankhani & Omid Pournik & Jamal Shahrabi & Fereidoun Azizi & Farzad Hadaegh & Davood Khalili
November 2015, Volume 35, Issue 8
- 932-936 Validation of a Short, 3-Item Version of the Subjective Numeracy Scale
by Candace D. McNaughton & Kerri L. Cavanaugh & Sunil Kripalani & Russell L. Rothman & Kenneth A. Wallston - 937-947 Presenting Numeric Information with Percentages and Descriptive Risk Labels
by Aleksandr Sinayev & Ellen Peters & Martin Tusler & Liana Fraenkel - 948-958 Preferences for Vaccination
by Jorien Veldwijk & Iris van der Heide & Jany Rademakers & A. Jantine Schuit & G. Ardine de Wit & Ellen Uiters & Mattijs S. Lambooij - 959-966 The CREATE Method for Expressing Continuous Outcome Data in Absolute Terms for Use in Patient Treatment Decision Aids
by Michael McGillion & J. Charles Victor & Sandra L. Carroll & Kelly Metcalfe & Sheila O’Keefe-McCarthy & Noorin Jamal & Heather M. Arthur & Robert McKelvie & E. Marc Jolicoeur & John G. Hanlon & James Stone & Joel Niznick & Robert Beanlands & Nelson Svorkdal & Peter Coyte & Bonnie Stevens & Dawn Stacey - 967-978 Is the “Heart Age†Concept Helpful or Harmful Compared to Absolute Cardiovascular Disease Risk? An Experimental Study
by Carissa Bonner & Jesse Jansen & Ben R. Newell & Les Irwig & Armando Teixeira-Pinto & Paul Glasziou & Jenny Doust & Shannon McKinn & Kirsten McCaffery - 979-986 Decision Aids
by James G. Dolan & Olena A. Cherkasky & Nancy Chin & Peter J. Veazie - 987-998 Implementation of Patient Decision Support Interventions in Primary Care
by Caroline K. Tietbohl & Katharine A. S. Rendle & Meghan C. Halley & Suepattra G. May & Grace A. Lin & Dominick L. Frosch - 999-1009 Informed Decision Making
by Margaret Holmes-Rovner & Jeffrey S. Montgomery & David R. Rovner & Laura D. Scherer & Jesse Whitfield & Valerie C. Kahn & Edgar C. Merkle & Peter A. Ubel & Angela Fagerlin - 1010-1022 My Lived Experiences Are More Important Than Your Probabilities
by Christine Holmberg & Erika A. Waters & Katie Whitehouse & Mary Daly & Worta McCaskill-Stevens - 1023-1036 An Approach to Assess Generalizability in Comparative Effectiveness Research
by Adam Steventon & Richard Grieve & Martin Bardsley - 1037-1048 Does Shared Decision Making in Cancer Treatment Improve Quality of Life? A Systematic Literature Review
by Michael Saheb Kashaf & Elizabeth McGill
October 2015, Volume 35, Issue 7
- 9-10 Stories of MDM
by Mary C. Politi - 812-814 How Should We Estimate the Cost-effectiveness of Interventions That Affect Reproduction?
by Evan R. Myers - 815-816 Validation Is Necessary but Insufficient
by R. Scott Braithwaite & Mark S. Roberts - 817-817 What Is Insufficient about Validation?
by J. Jaime Caro - 818-846 Evaluating Cost-effectiveness of Interventions That Affect Fertility and Childbearing
by Jeremy D. Goldhaber-Fiebert & Margaret L. Brandeau - 847-858 Understanding the Harms and Benefits of Cancer Screening
by Dafina Petrova & Rocio Garcia-Retamero & Edward T. Cokely - 859-871 Applying Multiple Criteria Decision Analysis to Comparative Benefit-Risk Assessment
by Tommi Tervonen & Huseyin Naci & Gert van Valkenhoef & Anthony E. Ades & Aris Angelis & Hans L. Hillege & Douwe Postmus - 872-887 Incorporating Psychological Predictors of Treatment Response into Health Economic Simulation Models
by Jen Kruger & Daniel Pollard & Hasan Basarir & Praveen Thokala & Debbie Cooke & Marie Clark & Rod Bond & Simon Heller & Alan Brennan - 888-901 Predicting the EQ-5D-3L Preference Index from the SF-12 Health Survey in a National US Sample
by Marcelo Coca Perraillon & Ya-Chen Tina Shih & Ronald A. Thisted - 902-911 Mapping from the Parkinson’s Disease Questionnaire PDQ-39 to the Generic EuroQol EQ-5D-3L
by Seamus Kent & Alastair Gray & Iryna Schlackow & Crispin Jenkinson & Emma McIntosh - 912-926 Mapping Functions in Health-Related Quality of Life
by Tracey A. Young & Clara Mukuria & Donna Rowen & John E. Brazier & Louise Longworth
August 2015, Volume 35, Issue 6
- 1-8 Preferred Reporting Items for Studies Mapping onto Preference-Based Outcome Measures: The MAPS Statement
by Stavros Petrou & Oliver Rivero-Arias & Helen Dakin & Louise Longworth & Mark Oppe & Robert Froud & Alastair Gray - 688-690 Choosing a Specialist
by Natalie Joseph-Williams & Freya Davies & Fiona Wood & Adrian Edwards - 691-702 Understanding Patients’ Preferences for Referrals to Specialists for an Asymptomatic Condition
by Robert Dunlea & Leslie Lenert - 703-713 Evolution of Pediatric Chronic Disease Treatment Decisions
by Ellen A. Lipstein & Maria T. Britto - 714-725 Predictive Modeling of Implantation Outcome in an In Vitro Fertilization Setting
by Asli Uyar & Ayse Bener & H. Nadir Ciray - 726-733 The Impact of Uncertainty in Barrett’s Esophagus Progression Rates on Hypothetical Screening and Treatment Decisions
by Sonja Kroep & Iris Lansdorp-Vogelaar & Alex van der Steen & John M. Inadomi & Marjolein van Ballegooijen - 734-744 Value of Genetic Testing for Hereditary Colorectal Cancer in a Probability-Based US Online Sample
by Sara J. Knight & Ateesha F. Mohamed & Deborah A. Marshall & Uri Ladabaum & Kathryn A. Phillips & Judith M. E. Walsh - 745-757 Impact of Diabetes E-Consults on Outpatient Clinic Workflow
by Brian Zoll & Pratik J. Parikh & Jennie Gallimore & Stephen Harrell & Brian Burke - 758-772 The ONCOTYROL Prostate Cancer Outcome and Policy Model
by Nikolai Mühlberger & Christina Kurzthaler & Rowan Iskandar & Murray D. Krahn & Karen E. Bremner & Willi Oberaigner & Helmut Klocker & Wolfgang Horninger & Annette Conrads-Frank & Gaby Sroczynski & Uwe Siebert - 773-783 Economic Evaluation of Pediatric Telemedicine Consultations to Rural Emergency Departments
by Nikki H. Yang & Madan Dharmar & Byung-Kwang Yoo & J. Paul Leigh & Nathan Kuppermann & Patrick S. Romano & Thomas S. Nesbitt & James P. Marcin - 784-796 Predicting Liver Transplant Capacity Using Discrete Event Simulation
by Hector Toro-DÃaz & Maria E. Mayorga & A. Sidney Barritt & Eric S. Orman & Stephanie B. Wheeler - 797-807 Improving Geographic Equity in Kidney Transplantation Using Alternative Kidney Sharing and Optimization Modeling
by Ashley E. Davis & Sanjay Mehrotra & John J. Friedewald & Mark S. Daskin & Anton I. Skaro & Michael M. Abecassis & Daniela P. Ladner
July 2015, Volume 35, Issue 5
- 564-566 Value of Information
by Nicky J. Welton & Howard H. Z. Thom - 567-569 Handling Parameter Uncertainty in Cost-Effectiveness Models Simply and Responsibly
by Sun-Young Kim & Louise B. Russell & Anushua Sinha - 570-583 Estimating the Expected Value of Sample Information Using the Probabilistic Sensitivity Analysis Sample
by Mark Strong & Jeremy E. Oakley & Alan Brennan & Penny Breeze - 584-595 Computing Expected Value of Partial Sample Information from Probabilistic Sensitivity Analysis Using Linear Regression Metamodeling
by Hawre Jalal & Jeremy D. Goldhaber-Fiebert & Karen M. Kuntz - 596-607 Cost-Effectiveness Uncertainty Analysis Methods
by Jonathan D. Campbell & R. Brett McQueen & Anne M. Libby & D. Eldon Spackman & Joshua J. Carlson & Andrew Briggs - 608-621 Accounting for Heterogeneity in Relative Treatment Effects for Use in Cost-Effectiveness Models and Value-of-Information Analyses
by Nicky J. Welton & Marta O. Soares & Stephen Palmer & Anthony E. Ades & David Harrison & Manu Shankar-Hari & Kathy M. Rowan - 622-632 US-Based Drug Cost Parameter Estimation for Economic Evaluations
by Joseph F. Levy & Patrick D. Meek & Marjorie A. Rosenberg - 633-647 Quantifying Parameter and Structural Uncertainty of Dynamic Disease Transmission Models Using MCMC
by Joke Bilcke & Ruth Chapman & Christina Atchison & Deborah Cromer & Helen Johnson & Lander Willem & Martin Cox & William John Edmunds & Mark Jit - 648-659 Modeling the Effect of Herd Immunity and Contagiousness in Mitigating a Smallpox Outbreak
by Ellie Graeden & Russel Fielding & Kyle E. Steinhouse & Ilan N. Rubin - 660-670 Estimating Cost-Effectiveness in Type 2 Diabetes
by Phil McEwan & Jason Gordon & Marc Evans & Thomas Ward & Hayley Bennett & Klas Bergenheim - 671-682 Exploring the Potential Cost-Effectiveness of Patient Decision Aids for Use in Adults with Obstructive Sleep Apnea
by Logan Trenaman & Mohsen Sadatsafavi & Fernanda Almeida & Najib Ayas & Larry Lynd & Carlo Marra & Dawn Stacey & Nick Bansback
May 2015, Volume 35, Issue 4
- 410-410 Corrigendum
by N/A - 412-418 The Neglected Topic
by J. S. Blumenthal-Barby & Emily Robinson & Scott B. Cantor & Aanand D. Naik & Heidi Voelker Russell & Robert J. Volk - 419-435 Patients or Volunteers? The Impact of Motivation for Trial Participation on the Efficacy of Patient Decision Aids: A Secondary Analysis of a Cochrane Systematic Review
by James G. Brown & Kerry E. Joyce & Dawn Stacey & Richard G. Thomson - 436-445 “I Don’t Know†My Cancer Risk
by Jennifer L. Hay & Heather Orom & Marc T. Kiviniemi & Erika A. Waters - 446-457 Decision Regret following Treatment for Localized Breast Cancer
by Kathryn A. Martinez & Yun Li & Ken Resnicow & John J. Graff & Ann S. Hamilton & Sarah T. Hawley - 458-466 Relationship between Physicians’ Uncertainty about Clinical Assessments and Patient-Centered Recommendations for Colorectal Cancer Screening in the Elderly
by Alexandra F. Dalton & Carol E. Golin & Denise Esserman & Michael P. Pignone & Donald E. Pathman & Carmen L. Lewis - 467-476 Clinicians’ Perceptions of the Benefits and Harms of Prostate and Colorectal Cancer Screening
by Emily A. Elstad & Anne Sutkowi-Hemstreet & Stacey L. Sheridan & Maihan Vu & Russell Harris & Valerie F. Reyna & Christine Rini & Jo Anne Earp & Noel T. Brewer - 477-486 Decision-making Processes among Prostate Cancer Survivors with Rising PSA Levels
by Megan Johnson Shen & Christian J. Nelson & Ellen Peters & Susan F. Slovin & Simon J. Hall & Matt Hall & Phapichaya Chaoprang Herrera & Elaine A. Leventhal & Howard Leventhal & Michael A. Diefenbach - 487-500 The Effect of Different Graphical and Numerical Likelihood Formats on Perception of Likelihood and Choice
by Jurriaan P. Oudhoff & Daniëlle R. M. Timmermans - 501-511 Is Patients’ Numeracy Related to Physical and Mental Health?
by Rocio Garcia-Retamero & Allen Andrade & Joseph Sharit & Jorge G. Ruiz - 512-524 Doctors and Numbers
by Tanner J. Caverly & Allan V. Prochazka & Brandon P. Combs & Brian P. Lucas & Shane R. Mueller & Jean S. Kutner & Ingrid Binswanger & Angela Fagerlin & Jacqueline McCormick & Shirley Pfister & Daniel D. Matlock - 525-532 Adapting Scott and Bruce’s General Decision-Making Style Inventory to Patient Decision Making in Provider Choice
by Sophia Fischer & Katja Soyez & Sebastian Gurtner - 533-538 Shared Decision Making in Senior Medical Students
by Claudia Zeballos-Palacios & Renato Quispe & Nicole Mongilardi & Carlos Diaz-Arocutipa & Carlos Mendez-Davalos & Natalia Lizarraga & Aldo Paz & Victor M. Montori & German Malaga - 539-557 Cognitive Biases and Heuristics in Medical Decision Making
by J. S. Blumenthal-Barby & Heather Krieger
April 2015, Volume 35, Issue 3
- 272-274 Medical Decision Making Reviewers, 2014
by N/A - 275-275 Call for Papers
by N/A - 276-291 Comparing and Explaining Differences in the Magnitude, Content, and Sensitivity of Utilities Predicted by the EQ-5D, SF-6D, HUI 3, 15D, QWB, and AQoL-8D Multiattribute Utility Instruments
by Jeff Richardson & Munir A. Khan & Angelo Iezzi & Aimee Maxwell - 292-304 Can Multi-attribute Utility Instruments Adequately Account for Subjective Well-being?
by Jeff Richardson & Gang Chen & Munir A. Khan & Angelo Iezzi - 305-315 The Lead Time Tradeoff
by José Luis Pinto-Prades & Eva RodrÃguez-MÃguez - 316-327 Quality of Life and Time to Death
by Maria Gheorghe & Werner B. F. Brouwer & Pieter H. M. van Baal - 328-340 A Comparison of Methods for Converting DCE Values onto the Full Health-Dead QALY Scale
by Donna Rowen & John Brazier & Ben Van Hout - 341-350 A Framework for Estimating Health State Utility Values within a Discrete Choice Experiment
by Angela Robinson & Anne Spencer & Peter Moffatt - 351-360 Use of Bayesian Markov Chain Monte Carlo Methods to Estimate EQ-5D Utility Scores from EORTC QLQ Data in Myeloma for Use in Cost-Effectiveness Analysis
by Samer A. Kharroubi & Richard Edlin & David Meads & Chantelle Browne & Julia Brown & Christopher McCabe - 361-370 Development of an EORTC-8D Utility Algorithm for Sri Lanka
by Sanjeewa Kularatna & Jennifer A. Whitty & Newell W. Johnson & Ruwan Jayasinghe & Paul A. Scuffham - 371-387 Catalog and Comparison of Societal Preferences (Utilities) for Lung Cancer Health States
by Angela C. Tramontano & Deborah L. Schrag & Jennifer K. Malin & Melecia C. Miller & Jane C. Weeks & J. Shannon Swan & Pamela M. McMahon - 388-397 Exploring the Response Shift Effect on the Quality of Life of Patients with Schizophrenia
by Mohamed Boucekine & Laurent Boyer & Karine Baumstarck & Aurelie Millier & Badih Ghattas & Pascal Auquier & Mondher Toumi - 398-402 Graphical Representation of Life Paths to Better Convey Results of Decision Models to Patients
by Stefania Rubrichi & Carla Rognoni & Lucia Sacchi & Enea Parimbelli & Carlo Napolitano & Andrea Mazzanti & Silvana Quaglini - 403-408 An Emerging Field of Research
by Ellen A. Lipstein & William B. Brinkman & Alexander G. Fiks & Kristin S. Hendrix & Jennifer Kryworuchko & Victoria A. Miller & Lisa A. Prosser & Wendy J. Ungar & David Fox
February 2015, Volume 35, Issue 2
- 1-3 Stories of MDM
by Brian J. Zikmund-Fisher - 136-138 Trust and Recognition
by James E. Stahl - 139-141 Psst, Have I Got a Model for You . .
by J. Jaime Caro - 143-144 Importance of Transparency in Assessing the Feasibility of Modeling Rare Disease
by Scott J. Johnson & Matthew R. Davis & Si-Tien Wang - 145-147 The Need for Transparency and Efficiency in Reimbursement Decisions Relating to Drugs for Rare Diseases
by Douglas A. Coyle & Matthew C. Cheung & Gerald A. Evans - 148-161 Calibration of Complex Models through Bayesian Evidence Synthesis
by Christopher H. Jackson & Mark Jit & Linda D. Sharples & Daniela De Angelis - 162-169 Calibration of Risk Prediction Models
by Ben Van Calster & Andrew J. Vickers - 170-182 Identifying Best-Fitting Inputs in Health-Economic Model Calibration
by Eva A. Enns & Lauren E. Cipriano & Cyrena T. Simons & Chung Yin Kong - 183-195 The Influence of Disease Risk on the Optimal Time Interval between Screens for the Early Detection of Cancer
by James F. O’Mahony & Joost van Rosmalen & Nino A. Mushkudiani & Frans-Willem Goudsmit & Marinus J. C. Eijkemans & Eveline A. M. Heijnsdijk & Ewout W. Steyerberg & J. Dik F. Habbema - 196-210 Modeling and Calibration for Exposure to Time-Varying, Modifiable Risk Factors
by Jeremy D. Goldhaber-Fiebert & Margaret L. Brandeau - 211-229 An Agent-based Simulation Model for Clostridium difficile Infection Control
by James Codella & Nasia Safdar & Rick Heffernan & Oguzhan Alagoz - 230-242 Performance of a Mathematical Model to Forecast Lives Saved from HIV Treatment Expansion in Resource-Limited Settings
by April D. Kimmel & Daniel W. Fitzgerald & Jean W. Pape & Bruce R. Schackman - 243-254 Development of a Microsimulation of Melanoma Mortality for Evaluating the Effectiveness of Population-Based Skin Cancer Screening
by Nora Eisemann & Annika Waldmann & Claus Garbe & Alexander Katalinic - 255-265 Modeling and Validating the Cost and Clinical Pathway of Colorectal Cancer
by Paal Joranger & Arild Nesbakken & Geir Hoff & Halfdan Sorbye & Arne Oshaug & Eline Aas
January 2015, Volume 35, Issue 1
- 1-167 36th Annual Meeting of the Society for Medical Decision Making
by N/A - 4-5 Angelina Jolie and Medical Decision Science
by Junaid Bhatti & Donald A. Redelmeier - 6-11 Subjective Numeracy and Preference to Stay with the Status Quo
by Liana Fraenkel & Meaghan Cunningham & Ellen Peters - 12-15 Improving Public Interpretation of Probabilistic Test Results
by Stefania Pighin & Michel Gonzalez & Lucia Savadori & Vittorio Girotto - 16-21 Cancer Information Seeking in the Digital Age
by Seth M. Noar & Benjamin M. Althouse & John W. Ayers & Diane B. Francis & Kurt M. Ribisl - 22-26 “Thinking about Numbers Is Not My Idea of Funâ€
by Wändi Bruine de Bruin & Simon J. McNair & Andrea L. Taylor & Barbara Summers & JoNell Strough - 27-36 The Impact of Numeracy on Verbatim Knowledge of the Longitudinal Risk for Prostate Cancer Recurrence following Radiation Therapy
by Daniel A. Hamstra & Skyler B. Johnson & Stephanie Daignault & Brian J. Zikmund-Fisher & Jeremy M. G. Taylor & Knoll Larkin & Alexander Wood & Angela Fagerlin - 37-45 Getting Ahead of Illness
by Aaron M. Scherer & Laura D. Scherer & Angela Fagerlin - 46-59 Efficacy of a Web-Based Intelligent Tutoring System for Communicating Genetic Risk of Breast Cancer
by Christopher R. Wolfe & Valerie F. Reyna & Colin L. Widmer & Elizabeth M. Cedillos & Christopher R. Fisher & Priscila G. Brust-Renck & Audrey M. Weil - 60-67 Germs Are Germs, and Why Not Take a Risk? Patients’ Expectations for Prescribing Antibiotics in an Inner-City Emergency Department
by David A. Broniatowski & Eili Y. Klein & Valerie F. Reyna - 68-80 Comparison of General Population, Patient, and Carer Utility Values for Dementia Health States
by Donna Rowen & Brendan Mulhern & Sube Banerjee & Rhian Tait & Caroline Watchurst & Sarah C. Smith & Tracey A. Young & Martin Knapp & John E. Brazier - 81-93 Measuring Family HRQoL Spillover Effects Using Direct Health Utility Assessment
by Lisa A. Prosser & Kara Lamarand & Acham Gebremariam & Eve Wittenberg - 94-105 Societal Preferences for Distributive Justice in the Allocation of Health Care Resources
by Chris Skedgel & Allan Wailoo & Ron Akehurst - 106-113 Quantifying Long-Term Care Preferences
by Jing Guo & R. Tamara Konetzka & Elizabeth Magett & William Dale - 114-131 Where Is the Evidence? A Systematic Review of Shared Decision Making and Patient Outcomes
by L. Aubree Shay & Jennifer Elston Lafata - 168-175 Author Index for Abstracts
by N/A
November 2014, Volume 34, Issue 8
- 940-943 The Fallacy of Interpreting Deaths and Driving Distances
by Donald A. Redelmeier - 944-947 Tackling Heterogeneity
by Charles E. Phelps - 948-950 Adopting Medical Technology
by Elise Berliner - 951-964 The Value of Heterogeneity for Cost-Effectiveness Subgroup Analysis
by Manuel A. Espinoza & Andrea Manca & Karl Claxton & Mark J. Sculpher - 965-975 STAR—People-Powered Prioritization
by Mara Airoldi & Alec Morton & Jenifer A. E. Smith & Gwyn Bevan - 976-986 Are Waiting List Prioritization Guidelines Being Followed in Australia?
by Meliyanni Johar - 987-995 A Model to Support Shared Decision Making in Electronic Health Records Systems
by Leslie Lenert & Robert Dunlea & Guilherme Del Fiol & Leslie Kelly Hall - 996-1005 Comparing Decisions for Malaria Testing and Presumptive Treatment
by Sanjay Basu & Sepideh Modrek & Eran Bendavid - 1006-1015 Decision to Adopt Medical Technology
by Heather Taffet Gold & Kimberly Pitrelli & Mary Katherine Hayes & Madhuvanti Mahadeo Murphy - 1016-1029 Opportunity Cost of Funding Drugs for Rare Diseases
by Doug Coyle & Matthew C. Cheung & Gerald A. Evans - 1030-1047 Early Benefit Assessment of Pharmaceuticals in Germany
by Katharina E. Fischer & Tom Stargardt - 1048-1058 Not Simply More of the Same
by Pepijn Vemer & Lucas M. A. Goossens & Maureen P. M. H. Rutten-van Mölken
October 2014, Volume 34, Issue 7
- 1-63 15th Biennial European Meeting of the Society for Medical Decision Making
by N/A - 824-825 Generalizability and Unaddressed Issues in Mapping
by Tracey Anne Young - 826-840 Methods for Systematic Reviews of Health Economic Evaluations
by Tim Mathes & Maren Walgenbach & Sunya-Lee Antoine & Dawid Pieper & Michaela Eikermann - 841-853 The Balance Beam Metaphor
by Robert M. Hamm & William Howard Beasley - 854-862 A Balance Beam Aid for Instruction in Clinical Diagnostic Reasoning
by Robert M. Hamm & William Howard Beasley & William Jay Johnson - 863-872 Underestimation of Uncertainties in Health Utilities Derived from Mapping Algorithms Involving Health-Related Quality-of-Life Measures
by Kelvin K. W. Chan & Andrew R. Willan & Michael Gupta & Eleanor Pullenayegum - 873-883 Mapping a Patient-Reported Functional Outcome Measure to a Utility Measure for Comparative Effectiveness and Economic Evaluations in Older Adults with Low Back Pain
by Sean D. Rundell & Brian W. Bresnahan & Patrick J. Heagerty & Bryan A. Comstock & Janna L. Friedly & Jeffrey G. Jarvik & Sean D. Sullivan - 884-898 Decision Aid Influences on Factors Associated with Patient Empowerment prior to Cancer Treatment Decision Making
by Dana L. Alden - 899-910 A Bayesian Mixed-Treatment Comparison Meta-analysis of Treatments for Alcohol Dependence and Implications for Planning Future Trials
by Stacia M. DeSantis & Huirong Zhu - 911-918 Use of Generalized Linear Mixed Models for Network Meta-analysis
by Yu-Kang Tu - 919-930 A Comparison of Direct and Indirect Methods for the Estimation of Health Utilities from Clinical Outcomes
by Mónica Hernández Alava & Allan Wailoo & Fred Wolfe & Kaleb Michaud - 931-935 Multicriteria Decision Making in Health Care Using the Analytic Hierarchy Process and Microsoft Excel
by Nuria Padilla-Garrido & Francisco Aguado-Correa & Virginia Cortijo-Gallego & Francisca López-Camacho
August 2014, Volume 34, Issue 6
- 696-698 The Varied Understandings of “Terminal Cancer†and Their Implications for Clinical Research and Patient Care
by Henry S. Perkins - 699-710 Toward Minimum Standards for Certifying Patient Decision Aids
by Natalie Joseph-Williams & Robert Newcombe & Mary Politi & Marie-Anne Durand & Stephanie Sivell & Dawn Stacey & Annette O’Connor & Robert J. Volk & Adrian Edwards & Carol Bennett & Michael Pignone & Richard Thomson & Glyn Elwyn - 711-719 Sample Size and Power When Designing a Randomized Trial for the Estimation of Treatment, Selection, and Preference Effects
by Robin M. Turner & Stephen D. Walter & Petra Macaskill & Kirsten J. McCaffery & Les Irwig - 720-730 The Understanding of Terminal Cancer and Its Relationship with Attitudes toward End-of-Life Care Issues
by June Koo Lee & Young Ho Yun & Ah Reum An & Dae Seog Heo & Byeong-Woo Park & Chi-Heum Cho & Sung Kim & Dae Ho Lee & Soon Nam Lee & Eun Sook Lee & Jung Hun Kang & Si-Young Kim & Jung Lim Lee & Chang Geol Lee & Yeun Keun Lim & Samyong Kim & Jong Soo Choi & Hyun Sik Jeong & Mison Chun